POZEN Inc. (NASDAQ: POZN) today announced that it has received an Advice/Information Request letter from the U.S. FDA which indicates ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE